Publication date: 24 November 2026 Source: Blood Advances, Volume 10, Issue 22 Author(s): Clarissa Skorupski, Lisa Chodirker, Lee Mozessohn, James T. England, James Kennedy, Matthew C. Cheung, Signy Chow, Jennifer Teichman, Nicola Goldberg, Samantha A. Hershenfeld, Hubert Tsui, Alexandre Mamedov, Mohammed Siddiqui, Liying Zhang, Rena Buckstein
A hemoglobin >120 g/L trends toward improved survival without increasing vascular events in patients with MDS treated with ESAs. // Blood Advances. – URL: https://www.sciencedirect.com/science/article/pii/S247395292600652X?dgcid=rss_sd_all
A hemoglobin >120 g/L trends toward improved survival without increasing vascular events in patients with MDS treated with ESAs. Blood Advances. https://www.sciencedirect.com/science/article/pii/S247395292600652X?dgcid=rss_sd_all
“A hemoglobin >120 g/L trends toward improved survival without increasing vascular events in patients with MDS treated with ESAs.” Blood Advances.
@article{article106848,
title = {A hemoglobin >120 g/L trends toward improved survival without increasing vascular events in patients with MDS treated with ESAs},
journal = {Blood Advances},
url = {https://www.sciencedirect.com/science/article/pii/S247395292600652X?dgcid=rss_sd_all}
}